Literature DB >> 11836431

Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Sung Hoon Back1, Yoon Ki Kim, Woo Jae Kim, Sungchan Cho, Hoe Rang Oh, Jung-Eun Kim, Sung Key Jang.   

Abstract

The translation of polioviral mRNA occurs through an internal ribosomal entry site (IRES). Several RNA-binding proteins, such as polypyrimidine tract-binding protein (PTB) and poly(rC)-binding protein (PCBP), are required for the poliovirus IRES-dependent translation. Here we report that a poliovirus protein, 3C(pro) (and/or 3CD(pro)), cleaves PTB isoforms (PTB1, PTB2, and PTB4). Three 3C(pro) target sites (one major target site and two minor target sites) exist in PTBs. PTB fragments generated by poliovirus infection are redistributed to the cytoplasm from the nucleus, where most of the intact PTBs are localized. Moreover, these PTB fragments inhibit polioviral IRES-dependent translation in a cell-based assay system. We speculate that the proteolytic cleavage of PTBs may contribute to the molecular switching from translation to replication of polioviral RNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836431      PMCID: PMC135932          DOI: 10.1128/jvi.76.5.2529-2542.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  84 in total

1.  Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff?

Authors:  V Kerekatte; B D Keiper; C Badorff; A Cai; K U Knowlton; R E Rhoads
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

2.  Signal sequences that target nuclear import and nuclear export of pre-mRNA-binding proteins.

Authors:  W M Michael; H Siomi; M Choi; S Piñol-Roma; S Nakielny; Q Liu; G Dreyfuss
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1995

3.  Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA.

Authors:  K L McKnight; S M Lemon
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  The La autoantigen contains a dimerization domain that is essential for enhancing translation.

Authors:  A W Craig; Y V Svitkin; H S Lee; G J Belsham; N Sonenberg
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

5.  Replication of poliovirus in Xenopus oocytes requires two human factors.

Authors:  A V Gamarnik; R Andino
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

6.  Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.

Authors:  B Hahm; S H Back; T G Lee; E Wimmer; S K Jang
Journal:  Virology       Date:  1996-12-15       Impact factor: 3.616

7.  Nuclear proteins bind to poliovirus 5' untranslated region.

Authors:  L Gutiérrez-Escolano; R M del Angel
Journal:  Arch Med Res       Date:  1996       Impact factor: 2.235

8.  Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry.

Authors:  L B Blyn; K M Swiderek; O Richards; D C Stahl; B L Semler; E Ehrenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA.

Authors:  A Kaminski; S L Hunt; J G Patton; R J Jackson
Journal:  RNA       Date:  1995-11       Impact factor: 4.942

10.  Switch from translation to RNA replication in a positive-stranded RNA virus.

Authors:  A V Gamarnik; R Andino
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  82 in total

1.  The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins.

Authors:  Sophie Delhaye; Vincent van Pesch; Thomas Michiels
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).

Authors:  Nogi Park; Nicholas J Schweers; Kurt E Gustin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

Review 3.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

4.  BiP internal ribosomal entry site activity is controlled by heat-induced interaction of NSAP1.

Authors:  Sungchan Cho; Sung Mi Park; Tae Don Kim; Jong Heon Kim; Kyong-Tai Kim; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

5.  Characterization of multimeric complexes formed by the human PTB1 protein on RNA.

Authors:  Caroline Clerte; Kathleen B Hall
Journal:  RNA       Date:  2006-01-23       Impact factor: 4.942

6.  Cellular protein modification by poliovirus: the two faces of poly(rC)-binding protein.

Authors:  Rushika Perera; Sarah Daijogo; Brandon L Walter; Joseph H C Nguyen; Bert L Semler
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

7.  Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors.

Authors:  Elena Y Dobrikova; Rachel N Grisham; Constanze Kaiser; Jennifer Lin; Matthias Gromeier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions.

Authors:  Woo Jae Kim; Sung Hoon Back; Vit Kim; Incheol Ryu; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Proline-rich transcript in brain protein induces stress granule formation.

Authors:  Jung-Eun Kim; Incheol Ryu; Woo Jae Kim; Ok-Kyu Song; Jeongeun Ryu; Mi Yi Kwon; Joon Hyun Kim; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2007-11-05       Impact factor: 4.272

10.  Interactions between PTB RRMs induce slow motions and increase RNA binding affinity.

Authors:  Caroline M Maynard; Kathleen B Hall
Journal:  J Mol Biol       Date:  2010-01-18       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.